Globe on Big Pharma R&D Failure
3 Comments
Recent Posts
The Government Doubles Down on News Sector Support: Fiscal Update Opens the Door to Tens of Millions in Tax Credits for Bell, Rogers and Corus 
The Illusion of Protection: Why Canada’s Growing Push to Ban Social Media for Kids Won’t Work 
The Law Bytes Podcast, Episode 266: Justin Safayeni on the Ontario Government’s Overnight Evisceration of Access to Information 
AI Without Canada: Why the Heritage Committee’s AI Report Could Lead to Less Canadian Content in the Training Data 
Addressing the AI Policy Challenge: My Appearance before the Standing Senate Committee on Transport and Communications
So, repeal C-22
If the drug companies can renege, then so can the goodies that were given to them be taken away.
Seems pretty straightforward to me.
Why aren’t there such things as charitable venture capital orgs? After-all many charities (eg JDRC) contribute to for-profit orgs. It seems to me that charitable donations would go much further if the beneficiaries of donations (R&D orgs) had to contribute returns back to charities. The role of charities like JDRC then would be to encourage R&D firms to take greater risks.
Hey, Michael! Don’t be so ungrateful or narrow minded. What about the bevy of busy lawyers who make gazillions every year doing “research” on their endless litany of pharmaceutical patent cases in the courts? What about all that useful literature and education directed at the medical profession, so that they are better informed about what pills their patients should pop? That takes a lot of “research and development”. And what about all the consumer focus group “research†that goes into those cute Cialis TV commercials?